NGL FINECHEM
Back to Cashflow Statement
|
NGL FINECHEM Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹36 Cr | ₹20 Cr | ₹35 Cr | ₹14 Cr | ₹27 Cr |
What is the latest Cash Flow from Operating Activities ratio of NGL FINECHEM ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹36 Cr |
| Mar2024 | ₹20 Cr |
| Mar2023 | ₹35 Cr |
| Mar2022 | ₹14 Cr |
| Mar2021 | ₹27 Cr |
How is Cash Flow from Operating Activities of NGL FINECHEM Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹36 Cr | 75.04 | |
| Mar2024 | ₹20 Cr | -42.00 | |
| Mar2023 | ₹35 Cr | 155.23 | |
| Mar2022 | ₹14 Cr | -49.46 | |
| Mar2021 | ₹27 Cr | - | |
Compare Cash Flow from Operating Activities of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,886.8 Cr | -0.7% | 33.2% | 173.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,639.0 Cr | 0.9% | -3.1% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,647.0 Cr | 2% | -2.1% | -0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,366.0 Cr | -2.9% | -0.3% | 36.4% | Stock Analytics | |
| CIPLA | ₹109,528.0 Cr | -2.4% | -3.8% | -10.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,819.0 Cr | -0.5% | -5% | -6.9% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | -0.7% |
33.2% |
173.7% |
| SENSEX | 4.9% |
2.8% |
-6.2% |
You may also like the below Video Courses